CAS NO: | 536697-79-7 |
包装 | 价格(元) |
1mg | 电议 |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
endothelial anandamide receptor antagonist
Cas No. | 536697-79-7 |
别名 | 1,3-二甲氧基-5-甲基-2-[(1R,6R)-3-甲基-6-(1-甲基乙烯基)-2-环己烯-1-基]苯 |
化学名 | (1S,2R)-2',6'-dimethoxy-4',5-dimethyl-2-(prop-1-en-2-yl)-1,2,3,4-tetrahydro-1,1'-biphenyl |
Canonical SMILES | CC1=C[C@H](C(C(OC)=CC(C)=C2)=C2OC)[C@H](C(C)=C)CC1 |
分子式 | C19H26O2 |
分子量 | 286.41 |
溶解度 | 30mg/mL in ethanol, or in DMSO, or in DMF |
储存条件 | Store at -20°C |
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
产品描述 | Abnormal cannabidiol is a synthetic regioisomer of cannabidiol that fails to elicit either central cannabinoid (CB1) or peripheral cannabinoid (CB2) responsiveness and is without psychotropic activity. It induces endothelium-dependent vasodilation via a CB1/CB2/nitric oxide-independent mechanism. O-1918 is a cannabidiol analog that acts as a selective antagonist of abnormal cannabidiol at the non-CB1/CB2 endothelial receptor. It does not bind to CB1 or CB2 receptors at concentrations up to 30 μM and inhibits the vasorelaxant effects of abnormal cannabidiol in vitro and in whole animals.1 It also blocks the abnormal cannabidiol-induced activation of the phosphatidylinositol 3-kinase/Akt pathway in human umbilical vein endothelial cells.[1] Reference: [1]. Offertáler, L., Mo, F.M., Bátkai, S., et al. Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor. Molecular Pharmacology 63(3), 699-705 (2003). |